Fecal microbiota transplantation recommended for treatment of C. difficile

Fecal microbiota transplantation now officially recommended for the effective treatment of C. difficile infection

2014-09-25

(Press-News.org) (Vienna, October 26, 2014) The transplantation of faecal microbiota from a healthy donor has been shown in recent clinical studies to be a safe and highly effective treatment for recurrent Clostridium difficile (C. difficile) infection and is now recommended in European treatment guidelines.1,2 Faecal microbiota transplantation (FMT) has emerged as a revolutionary, potentially life-saving treatment for this common, difficult-to-treat infection, and is showing promise in the management of other microbiota-related conditions.3,4

Presenting at the 22nd United European Gastroenterology Week (UEG Week 2014) in Vienna, Austria, Professor Antonio Gasbarrini from the Gemeli University Hospital in Rome believes that FMT should now be used more widely in order to reduce both the clinical and economic burden of microbiota-related disease. "FMT is an old procedure that has gained in popularity in recent years," he says. "When used in patients with recurrent C. difficile infections, which are extremely difficult to treat, FMT eradicates the bacteria in around 90% of cases with a good safety profile."

The challenges of C. difficile infection

C. difficile infection is the most common cause of hospital-acquired diarrhoea, and is associated with significant morbidity and mortality in hospitalized patients. Infection rates have been rising rapidly in Europe and reports of emerging new strains, growing antibiotic resistance, and increased susceptibility in non-hospitalized individuals are of grave concern. C. difficile infection causes severe diarrhoea, intestinal inflammation and toxin-mediated cell death that, in severe cases, can lead to shock, hypotension, ileus or megacolon. Standard first-line therapies include the antibiotics, vancomycin or metronidazole, which are initially effective in most individuals. Unfortunately, approximately 20% of successfully-treated patients will have an infection recurrence, and many of these will experience multiple recurrences.5

"Recurrent C. difficile infections are particularly difficult to treat, with long courses of antibiotics further disrupting the normal gut microflora, putting the patient at great risk of serious complications such as sepsis or perforation of the bowel," says Prof. Gasbarrini. "There is an urgent need for more effective treatments for recurrent C. difficile infections and FMT is definitely one of them."

FMT for C. difficile infection

FMT is an innovative treatment that was first described in C. difficile infection in the 1950s, and is being used increasingly in everyday practice. In FMT, healthy microbiota harvested from a donated stool sample is transplanted into the intestine of the recipient – often by colonoscopy or enema – where it helps to restore the normal composition of the gut flora and overcome the toxic consequences of C. difficile infection.

Studies in patients with C. difficile infection have confirmed that the treatment has a good safety record and is highly effective – quickly eradicating recurrent infections in around 90% of patients.5,6 While once considered a last-resort option for only the brave or desperate, FMT is now officially recommended in influential European treatment guidelines for recurrent C. difficile infections.1,2

"FMT can be considered a very simple form of organ transplantation that does not require immunological matching of donor and recipient and does not need immunosuppression after the procedure," says Prof. Gasbarrini. "I am delighted that FMT has now been formally recognised as an effective treatment for recurrent C. difficile infection and I hope the technique will now be used more widely in an effort to relieve some of the burden of this troublesome infection."

INFORMATION:

References

1. Debast SB, et al. Clin Microbiol Infect 2014; 20 (Suppl 2): 1-26.
2. National Institute for Health and Care Excellence. Faecal microbiota transplant for recurrent Clostridium difficile infection. NICE interventional procedure guidance 485. March 2014.
3. Cammarota, et al. Intern Emerg Med 2014; 9: 365-373.
4. Smits LP, et al. Gastroenterology 2013; 145: 946-953.
5. Cammarota G, et al. J Clin Gastroenterol 2014 Jan 16.
6. Van Nood E, et al. N Engl J Med 2013; 368: 407-415.

Notes to Editors

About UEG Week

UEG Week is the largest and most prestigious gastroenterology meeting in Europe and has developed into a global congress. It attracts over 14,000 participants each year, from more than 120 countries, and numbers are steadily rising. UEG Week provides a forum for basic and clinical scientists from across the globe to present their latest research in digestive and liver diseases, and also features a two-day postgraduate course that brings together top lecturers in their fields for a weekend of interactive learning.

From October 18-22, 2014, UEG will connect everyone to its annual meeting via livestream on http://www.ueg.eu. State-of-the-art lectures of Europe's largest GI meeting may be followed online from around the world. Include #UEGWeek in your tweets. UEG Week 24/7 features all recorded sessions from UEG Week and provides convenient and direct access to the complete congress material, including E-posters and abstracts.

About UEG

UEG, or United European Gastroenterology, is a professional non-profit organisation combining all the leading European societies concerned with digestive diseases. Together, its member societies represent over 22,000 specialists, working across medicine, surgery, paediatrics, gastrointestinal oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge.

To advance standards of gastroenterological care and knowledge across Europe and the world, UEG offers numerous activities and initiatives besides UEG Week, including:

UEG Education, the universal source of knowledge in gastroenterology, providing online and classroom courses, a huge online library and delivering the latest GI news, fostering debate and discussion Training Support, funding for innovative training and educational programmes, as well as international scientific and professional co-operations UEG Journal, published bi-monthly, covering translational and clinical studies from all areas of gastroenterology EU Affairs, promoting research, prevention, early diagnosis and treatment of digestive diseases, and helping develop an effective health policy for Europe

Find out more about UEG's work. Visit http://www.ueg.eu

Follow UEG on Twitter @my_ueg and @UEGMedia

ELSE PRESS RELEASES FROM THIS DATE:

In the face of uncertainty, the brain chooses randomness as the best strategy

2014-09-25

AUDIO: Editor Karen Carniol interviews Dr. Alla Karpova on her latest Cell paper. Click here for more information. Past experience is usually a reliable guide for making decisions, but in unpredictable and challenging situations, it might make more sense to take risks. A study published by Cell Press September 25th in the journal Cell shows that, in competitive situations, rats abandon their normal tactic of using past experience to make decisions and instead make random choices ...

How the brain gains control over Tourette syndrome

2014-09-25

Tourette syndrome is a developmental disorder characterized by involuntary, repetitive, and stereotyped movements or utterances. Now researchers reporting in the Cell Press journal Current Biology on September 25 have new evidence to explain how those with Tourette syndrome in childhood often manage to gain control over those tics. In individuals with the condition, a portion of the brain involved in planning and executing movements shows an unusual increase compared to the average brain in the production of a primary inhibitory neurotransmitter known as GABA. The paradoxical ...

Modified vitamin D shows promise as treatment for pancreatic cancer

2014-09-25

VIDEO: Salk scientists find that a vitamin D-derivative makes tumors vulnerable to chemotherapy. Click here for more information. LA JOLLA—A synthetic derivative of vitamin D was found by Salk Institute researchers to collapse the barrier of cells shielding pancreatic tumors, making this seemingly impenetrable cancer much more susceptible to therapeutic drugs. The discovery has led to human trials for pancreatic cancer, even in advance of its publication today in the journal ...

How physical exercise protects the brain from stress-induced depression

2014-09-25

Physical exercise has many beneficial effects on human health, including the protection from stress-induced depression. However, until now the mechanisms that mediate this protective effect have been unknown. In a new study in mice, researchers at Karolinska Institutet in Sweden show that exercise training induces changes in skeletal muscle that can purge the blood of a substance that accumulates during stress, and is harmful to the brain. The study is being published in the prestigious journal Cell. "In neurobiological terms, we actually still don't know what depression ...

Brain chemical potential new hope in controlling Tourette Syndrome tics

2014-09-25

A chemical in the brain plays a vital role in controlling the involuntary movements and vocal tics associated with Tourette Syndrome (TS), a new study has shown. The research by psychologists at The University of Nottingham, published in the latest edition of the journal Current Biology, could offer a potential new target for the development of more effective treatments to suppress these unwanted symptoms. The study, led by PhD student Amelia Draper under the supervision of Professor Stephen Jackson, found that higher levels of a neurochemical called GABA in a part ...

Super enhancers in the inflamed endothelium

2014-09-25

Boston, MA – Normally, the lining of blood vessels, or endothelium, when at rest, acts like Teflon, ignoring the many cells and other factors rushing by in the bloodstream. In response to inflammatory signals, as well as other stimuli, endothelial cells change suddenly and dramatically—sending out beacons to attract inflammatory cells, changing their surface so those cells can stick and enter tissues, and initiating a complex cascade of responses essential to fighting infection and dealing with injury. Unfortunately, these same endothelial responses also promote atherosclerosis, ...

Novel compound prevents metastasis of multiple myeloma in mouse studies

2014-09-25

BOSTON –– In an advance against the problem of cancer metastasis, Dana-Farber Cancer Institute scientists have shown that a specially developed compound can impede multiple myeloma from spreading to the bones in mice. The findings, published in the Sept. 25 issue of Cell Reports, suggest the technique can protect human patients, as well, from one of the most deadly aspects of cancer. The research involves a new approach to the challenge of cancer metastasis, the process by which tumors spread to and colonize distant parts of the body. Whereas research has traditionally ...

Dinosaur family tree gives fresh insight into rapid rise of birds

2014-09-25

The most comprehensive family tree of meat-eating dinosaurs ever created is enabling scientists to discover key details of how birds evolved from them. The study has shown that the familiar anatomical features of birds – such as feathers, wings and wishbones – all first evolved piecemeal in their dinosaur ancestors over tens of millions of years. However, once a fully functioning bird body shape was complete, an evolutionary explosion began, causing a rapid increase in the rate at which birds evolved. This led eventually to the thousands of avian species that we know ...

Strategic or random? How the brain chooses

2014-09-25

Many of the choices we make are informed by experiences we've had in the past. But occasionally we're better off abandoning those lessons and exploring a new situation unfettered by past experiences. Scientists at the Howard Hughes Medical Institute's Janelia Research Campus have shown that the brain can temporarily disconnect information about past experience from decision-making circuits, thereby triggering random behavior. In the study, rats playing a game for a food reward usually acted strategically, but switched to random behavior when they confronted a particularly ...

New protein players found in key disease-related metabolic pathway

2014-09-25

CAMBRIDGE, Mass. (September 25, 2014) – To coordinate their size and growth with current environmental conditions, cells rely on the mechanistic target of rapamycin complex 1 (mTORC1) pathway, which senses cellular stresses, growth factors, and the availability of nutrients, such as amino acids and glucose. For years, Whitehead Institute Member David Sabatini and his lab have been teasing apart the numerous proteins involved in this vital metabolic pathway, in part because mTORC1 function is known to be deregulated in a variety of diseases, including diabetes, epilepsy, ...

Fecal microbiota transplantation recommended for treatment of C. difficile

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: